These cells, marked by proteins such as prominin-1 (CD133), SRY-box transcription factor 2 (SOX2), and polycomb complex protein BMI-1 (BMI-1), contribute to therapy resistance and tumor recurrence. This evidence concerns the gene PROM1 and neoplasm.